Aggressive Adalimumab Rx in Moderate Crohns and Elevated CRP?

A new analysis supports a strategy of aggressive adalimumab treatment in moderately ill patients with Crohn's disease who have a CRP of 10 ml/L or greater.
Source: Consultant Live - Category: Primary Care Source Type: news